4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Purity ≥99.5% (GC) Lub Hoobkas Kub Muag
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com
Tshuaj npe | 4,6-Dichloro-2-Methylpyrimidine |
Synonyms | 2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine |
CAS Nr | 1780-26-3 : kuv |
CAT Number | Qauv: RF-PI687 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C5H4Cl2N2 |
Molecular Luj | 163.00 Nws |
Melting Point | 41.5 ~ 45.5 ℃ (lit.) |
Solubility (Soluble hauv) | Methanol |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb los yog Off-White Crystalline Hmoov |
Purity / Analysis Method | ≥99.5% (GC) |
Poob rau ziab | ≤0.50% |
Residue ntawm Ignition | ≤ 0.20% |
Ib leeg Impurity | ≤0.50% |
Tag nrho cov impurities | ≤0.50% |
Test Standard | Enterprise Standard |
Kev siv | Pharmaceutical Intermediate;Dasatinib / Moxonidine Intermediate |
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Txoj Kev
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) yog siv rau hauv kev sib txuas ntawm cov tshuaj intermediates thiab APIs.Kev npaj cov khoom: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine yog ib yam tshiab ntawm cov tshuaj tiv thaiv hypertensive, feem ntau siv los kho cov ntshav siab tseem ceeb.Piv rau cov laus hauv nruab nrab-ua yeeb yam antihypertensives, Moxonidine khi nrog ntau dua affinity rau imidazoline I1-receptor dua li α2-receptor.Dasatinib yog lub qhov ncauj muaj zog oncogenic kinase inhibitor, uas tuaj yeem thaiv cov teeb liab ntawm cov qog nqaij hlav qog ua kom nrawm nrawm, thaum lub Tsib Hlis 2009, US Food and Drug Administration (FDA) tau tso cai tso cai muag dasatinib, nws tau raug siv rau kev kho mob ntau yam mob. myeloid leukemia (CML), suav nrog kev kho mob myeloid leukemia mob ntev uas tiv taus lossis ua tsis taus rau cov kev kho mob suav nrog imatinib mesylate., Philadelphia chromosome-positive mob lymphoblastic leukemia (Ph + ALL) thiab kev kho mob ntawm cov neeg mob qog nqaij hlav.